ACIU · AC Immune SA
United States · RS rating 32 · As of 2026-10-14
| Price | 2.40 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 22 / 85 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 10 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -64.0% |
| Distance from 52-week high | +37.5% |
| Market cap (USD) | $302.3M |